Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorPublished on 10.06.2015
Alkylating the Nitrogen of an amide bond results in peptoid structures, leading to conformational restrains, like N-methylation and allows backbone derivatisation. Altering cytotoxicity, bacterial cell selectivity and receptor pharmacology through formation of peptoid derivatives has been published for Cilengitide, Piscidin 1, and MC3, MC4 and MC5 receptor agonists. Sophisticated building blocks furthermore enable the design of macrocycles through intermolecular crosslinking or backbone stabilization through intermolecular ring-closure.
With the example of Cilengitide it has been shown that the N-(4-azidobutyl) group exerts similar conformational restraints as a backbone N-Me group, but additionally it allows conjugation of a desired molecule either via click chemistry or - after azide reduction - via acylation or reductive alkylation. The introduction with simple and robust standard SPPS techniques is described.
Head-to-tail cyclization of N-substituted glycine peptoid oligomers has been shown in another example (MC4 receptor agonist) by bridging the side chains of a peptoid via Cu(I)-catalyzed azide–alkyne cycloaddition. Under dilute conditions, intramolecular side chain tethering is favored over formation of intermolecular crosslinked macrocycles.
In the case of Piscidin 1 (Pis-1), a novel cytotoxic peptide with a cationic α-helical structure, a peptoid residue-substituted derivative has been designed, in which Gly8 of Pis-1 was replaced with Nlys (Lys peptoid residue). Pis-1[NkG] had higher antibacterial activity and lower cytotoxicity against mammalian cells than Pis-1. Pis-1 has a rigid bent structure at Pro8 whereas Pis-1[NkG] existed in a dynamic equilibrium of two conformers with a flexible hinge structure at Nlys8.